Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome

Irritable bowel syndrome (IBS) is a chronic functional disorder and its development may be linked, directly and indirectly, to intestinal dysbiosis. Here we investigated the interactions between IBS symptoms and the gut microbiome, including the relation to rifaximin (1200 mg daily; 11.2 g per a tre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gut Microbes
Main Authors: Zeber-Lubecka, Natalia, Kulecka, Maria, Ambrozkiewicz, Filip, Paziewska, Agnieszka, Goryca, Krzysztof, Karczmarski, Jakub, Rubel, Tymon, Wojtowicz, Wojciech, Mlynarz, Piotr, Marczak, Lukasz, Tomecki, Roman, Mikula, Michal, Ostrowski, Jerzy
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Research Paper/Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5046165/
https://ncbi.nlm.nih.gov/pubmed/27662586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19490976.2016.1215805
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados